Cargando…

Is eNAMPT/visfatin a potential serum marker of papillary thyroid cancer?

PURPOSE: The role of nicotinamide phosphoribosyltransferase (NAMPT)/visfatin in a more aggressive course of many malignancies has been proven. Previous studies have noticed the importance of visfatin in thyroid neoplastic tissue, but the diagnostic and prognostic value of its serum concentration has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sawicka-Gutaj, Nadia, Ziółkowska, Paulina, Derwich, Aleksandra, Gut, Paweł, Czarnywojtek, Agata, Kloska, Michał, Ruchała, Marek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	New Perspectives in the Diagnosis and Treatment of Endocrine Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016592/ https://www.ncbi.nlm.nih.gov/pubmed/35450096 http://dx.doi.org/10.1177/20420188221090005

Ejemplares similares

Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022)

Effect of restoration of euthyroidism on visfatin concentrations and body composition in women
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

EZH2 and SMYD3 expression in papillary thyroid cancer
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

Linkage of NAMPT promoter variants to eNAMPT secretion, plasma eNAMPT levels, and ARDS severity
por: Lynn, Heather, et al.
Publicado: (2023)

Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021)

Endothelial eNAMPT drives EndMT and preclinical PH: rescue by an eNAMPT-neutralizing mAb
por: Ahmed, Mohamed, et al.
Publicado: (2021)

Circulating Visfatin in Hypothyroidism Is Associated with Free Thyroid Hormones and Antithyroperoxidase Antibodies
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2016)

Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody
por: Quijada, Hector, et al.
Publicado: (2021)

Advancements in the treatment of differentiated thyroid cancer
por: Stewart, Latoya A., et al.
Publicado: (2021)

Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis
por: Bartz-Kurycki, Marisa A., et al.
Publicado: (2021)

Evolution of anaplastic thyroid cancer management: perspectives in the era of precision oncology
por: Agosto Salgado, Sarimar
Publicado: (2021)

Advances in the diagnosis and the management of primary hyperparathyroidism
por: Islam, Ana Kashfia
Publicado: (2021)

Multiple endocrine neoplasia 1: a broad overview
por: Thompson, Rachel, et al.
Publicado: (2021)

Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm
por: Romanelli, Kristen, et al.
Publicado: (2021)

Multiple endocrine neoplasia 2: an overview
por: Saravana-Bawan, B, et al.
Publicado: (2022)

Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment
por: Shariq, Omair A., et al.
Publicado: (2021)

Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome
por: Romacho, Tania, et al.
Publicado: (2020)

Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
por: Derwich, Aleksandra, et al.
Publicado: (2023)

The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
por: Torretta, Simone, et al.
Publicado: (2020)

Eye symptoms in patients with benign thyroid diseases
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

Identification of a Signature Comprising 5 Soluble Carrier Family Genes to Predict the Recurrence of Papillary Thyroid Carcinoma
por: Han, Rui, et al.
Publicado: (2021)

Visfatin/Nampt: An Adipokine with Cardiovascular Impact
por: Romacho, Tania, et al.
Publicado: (2013)

Circulating blood eNAMPT drives the circadian rhythms in locomotor activity and energy expenditure
por: Park, Jae Woo, et al.
Publicado: (2023)

Hindgut neuroendocrine neoplasms – characteristics and prognosis
por: Gut, Paweł, et al.
Publicado: (2017)

Incidence of pituitary autoantibodies in idiopathic diabetes insipidus
por: Gut, Paweł, et al.
Publicado: (2018)

The potential utility of the SAGIT instrument in the clinical assessment of patients with acromegaly, a large single-centre study
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2023)

Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2
por: Casanova, Nancy G., et al.
Publicado: (2022)

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer
por: Travelli, Cristina, et al.
Publicado: (2023)

Management of the hormonal syndrome of neuroendocrine tumors
por: Gut, Paweł, et al.
Publicado: (2016)

Visfatin/PBEF/Nampt: A New Cardiovascular Target?
por: Peiró, Concepción, et al.
Publicado: (2010)

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma
por: Audrito, Valentina, et al.
Publicado: (2018)

eNAMPT Is Localised to Areas of Cartilage Damage in Patients with Hip Osteoarthritis and Promotes Cartilage Catabolism and Inflammation
por: Philp, Ashleigh M., et al.
Publicado: (2021)

Unexpected conversion from hypothyroidism to an euthyroid state due to Graves’ disease in a patient with an ectopic thyroid
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2013)

The Role of Activation of PI3K/AKT/mTOR and RAF/MEK/ERK Pathways in Aggressive Pituitary Adenomas—New Potential Therapeutic Approach—A Systematic Review
por: Derwich, Aleksandra, et al.
Publicado: (2023)

Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment
por: Kieswich, Julius, et al.
Publicado: (2016)

Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: Novel biomarker and therapeutic target
por: Sun, Belinda L, et al.
Publicado: (2020)

Colon-Targeted eNAMPT-Specific Peptide Systems for Treatment of DSS-Induced Acute and Chronic Colitis in Mouse
por: Kim, Jae-Sung, et al.
Publicado: (2022)

Radioiodine therapy and Graves’ disease – Myths and reality
por: Plazinska, Maria Teresa, et al.
Publicado: (2020)

The Role of Thyroid Hormones on Skeletal Muscle Thermogenesis
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2022)

Hypoxia and the Tumor Microenvironment
por: Li, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vbs0oq1mihpo0f9cs9ve2s5df1